Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response (Q38285639)

1 September 2017

1 reference

title

Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response (English)

1 reference

1 September 2017

0 references

Stamatina Iliodromiti

series ordinal

1

1 reference

PubMed ID

25489055

1 September 2017

Richard A Anderson

series ordinal

2

1 reference

PubMed ID

25489055

1 September 2017

Scott M Nelson

series ordinal

3

1 reference

1 September 2017

8 December 2014

1 reference

Human Reproduction Update

1 September 2017

1 reference

1 September 2017

21

1 reference

1 September 2017

698-710

1 reference

1 September 2017

6

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

1 September 2017

1 reference

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Anti-müllerian hormone is not associated with cardiometabolic risk factors in adolescent females

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Measuring anti-Müllerian hormone for the assessment of ovarian reserve: when and for whom is it indicated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Activation of the aryl hydrocarbon receptor by a component of cigarette smoke reduces germ cell proliferation in the human fetal ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Ovarian antral folliculogenesis during the human menstrual cycle: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Ovarian antral follicle subclasses and anti-mullerian hormone during normal reproductive aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Antral follicle counts are related to age at natural fertility loss and age at menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

A systematic review of tests predicting ovarian reserve and IVF outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

The antral follicle count: practical recommendations for better standardization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Prognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Circadian variation in concentration of anti-Müllerian hormone in regularly menstruating females: relation to age, gonadotrophin and sex steroid levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Use of the antral follicle count to predict the outcome of assisted reproductive technologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Elevated anti-Müllerian hormone (AMH) and inhibin B levels in prepubertal girls with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Age-specific serum antimüllerian hormone levels in women with and without polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Intraobserver and interobserver reliability of automated antral follicle counts made using three-dimensional ultrasound and SonoAVC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Intracycle variation in number of antral follicles stratified by size and in endocrine markers of ovarian reserve in women with normal ovulatory menstrual cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

The physiology and clinical utility of anti-Mullerian hormone in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Reproductive and lifestyle determinants of anti-Müllerian hormone in a large population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Patient acceptance of transvaginal sonography in the early pregnancy unit setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Intercycle variabilities of basal antral follicle count and ovarian volume in subfertile women and their relationship to reproductive aging: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Early follicular antimüllerian hormone as an indicator of ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Active smoking compromises IVF outcome and affects ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Ovarian reserve and in vitro fertilization cycles outcome according to women smoking status and stimulation regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Cigarette smoke exposure leads to follicle loss via an alternative ovarian cell death pathway in a mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

First fully automated immunoassay for anti-Müllerian hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Variation in antimüllerian hormone concentration during the menstrual cycle may change the clinical classification of the ovarian response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Serum levels of antimüllerian hormone in early maturing girls before, during, and after suppression with GnRH agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Reproductive aging and variability in the ovarian antral follicle count: application in the clinical setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

An immunoassay to detect human müllerian inhibiting substance in males and females during normal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

The interobserver reliability of off-line antral follicle counts made from stored three-dimensional ultrasound data: a comparative study of different measurement techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Three-dimensional ultrasound improves the interobserver reliability of antral follicle counts and facilitates increased clinical work flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

An Enzyme Linked Immunoassay for Anti-Müllerian Hormone: A New Tool for the Evaluation of Testicular Function in Infants and Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Antimüllerian hormone levels decrease in women using combined contraception independently of administration route.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Investigation of the infertile couple: a one-stop ultrasound-based approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

A validated model of serum anti-müllerian hormone from conception to menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Data-driven assessment of the human ovarian reserve.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Biological variability in serum anti-Müllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Serum anti-Mullerian hormone throughout the human menstrual cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Age-specific nomogram for the decline in antral follicle count throughout the reproductive period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma or non-Hodgkin-lymphoma--evaluation by using antimüllerian hormone and retrieved oocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Ovarian volume and antral follicle count assessed by MRI and transvaginal ultrasonography: a methodological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Antral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilization outcome in an egg donation program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Intraobserver and interobserver reproducibility of ovarian volume, antral follicle count, and vascularity indices obtained with transvaginal 3-dimensional ultrasonography, power Doppler angiography, and the virtual organ computer-aided analysis imag

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Biomarkers of ovarian response: current and future applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

The ageing ovary and uterus: new biological insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Reference range for the antimüllerian hormone Generation II assay: a population study of 10,984 women, with comparison to the established Diagnostics Systems Laboratory nomogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Intra-cycle fluctuations of anti-Müllerian hormone in normal women with a regular cycle: a re-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Follicular growth in fetal and prepubertal ovaries of humans and other primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Updated assays for inhibin B and AMH provide evidence for regular episodic secretion of inhibin B but not AMH in the follicular phase of the normal menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Anti-Mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Impact of breast cancer on anti-mullerian hormone levels in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

The impact of depot GnRH agonist on AMH levels in healthy reproductive-aged women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Comparability of antimüllerian hormone levels among commercially available immunoassays

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

The effect of weight loss on anti-Müllerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Cardiovascular Risk and Risk Scores: ASSIGN, Framingham, QRISK and others: how to choose

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Cigarette smoke causes follicle loss in mice ovaries at concentrations representative of human exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Decreased serum anti-Müllerian hormone levels in girls with newly diagnosed cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Human ovarian reserve from conception to the menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

A multicentre evaluation of the new Beckman Coulter anti-Mullerian hormone immunoassay (AMH Gen II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Toward a clearer definition of confounding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Antral follicle count predicts natural menopause in a population-based sample: the Coronary Artery Risk Development in Young Adults Women's Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

A single-centre evaluation of two new anti-Mullerian hormone assays and comparison with the current clinical standard assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Chronological age vs biological age: an age-related normogram for antral follicle count, FSH and anti-Mullerian hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

What does it take to make a developmentally competent mammalian egg?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Within-laboratory and between-laboratory variability in the measurement of anti-müllerian hormone determined within an external quality assurance scheme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

Anti-Müllerian hormone levels and antral follicle count in women enrolled inin vitrofertilization cycles: Relationship to lifestyle factors, chronological age and reproductive history

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU062

21 January 2018

Identifiers

DOI

10.1093/HUMUPD/DMU062

1 reference

1 September 2017

1 reference

PubMed ID

25489055